Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 2Soliqua
02 1Soliqua/Suliqua
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Insulin Glargine and Lixisenatide
Main Therapeutic Indication : Diabetes
Currency : USD
2022 Revenue in Millions : 236
2021 Revenue in Millions : 215
Growth (%) : 10
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Insulin Glargine and Lixisenatide
Main Therapeutic Indication : Diabetes
Currency : USD
2017 Revenue in Millions : 32
2016 Revenue in Millions : 0
Growth (%) : New Launch
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Insulin Glargine And Lixisenatide
Main Therapeutic Indication : Diabetes
Currency : USD
2018 Revenue in Millions : 82
2017 Revenue in Millions : 29
Growth (%) : 181%
LOOKING FOR A SUPPLIER?